An improved understanding of neuropathic pain
Corresponding Author
Prof. Troels S. Jensen MD, PhD
Department of Neurology and Danish Pain Research Center, Aarhus University Hospital, 8000 Aarhus C, Denmark
Department of Neurology and Danish Pain Research Center, Aarhus University Hospital, 8000 Aarhus C, Denmark. Tel.: +45-8949-3283; Fax: +45-8949-3300; E-mail: [email protected]Search for more papers by this authorCorresponding Author
Prof. Troels S. Jensen MD, PhD
Department of Neurology and Danish Pain Research Center, Aarhus University Hospital, 8000 Aarhus C, Denmark
Department of Neurology and Danish Pain Research Center, Aarhus University Hospital, 8000 Aarhus C, Denmark. Tel.: +45-8949-3283; Fax: +45-8949-3300; E-mail: [email protected]Search for more papers by this authorAbstract
Neuropathic pain represents a series of relatively uncommon chronic pain conditions, caused by lesions or dysfunctions of peripheral or central afferent pathways in the nervous system. The symptoms and signs of neuropathic pain can all be explained by a neuronal hyperexcitability at the site of the nerve lesion, which subsequently and in a dynamic fashion recruits more central sites. The manifestations of such neuronal hyperexcitability are therefore rather similar, irrespective of the causes or sites of the lesions. The key findings in neuropathic pain are: (a) pain in an area with sensory loss; (b) positive sensory symptoms such as dysesthaesia and allodynia in the injured area, where sensory discrimination is abolished; and (c) an abnormal sympathetic activity. Our understanding of the mechanisms underlying neuronal hyperexcitability has increased dramatically within the last decade, and accordingly, it has been suggested that pain be classified according to a mechanism-based approach. The challenge for an improved understanding of neuropathic pain—which is the key for better treatment—lies in elucidating the relationships between symptoms, signs, aetiology, anatomical lesions, and underlying mechanisms. At present, this is not a trivial task. © 2002 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Science Ltd.
References
- Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS The incidence of central post-stroke pain. Pain 1995; 61: 187–193.
-
Attal N,
Gaude V,
Brasseur L,
Dupuy M,
Guirimand F,
Parker F,
Bouhassira D.
Intravenous lidocaine in central pain: a double-blind, placebo-controlled psychophysical study.
Neurology
2000; 1: 564–574.
10.1212/WNL.54.3.564 Google Scholar
- Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D. Effects of iv morphine in central pain: a randomized placebo-controlled study. Neurology 2002; 58: 554–563.
- Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain 2000; 16: S12–S20.
- Besson JM The neurobiology of pain. Lancet 1999; 353: 1610–1615.
- Bennett GJ Animal models of neuropathic pain. In: GB Gebhart, DL Hammond, TS Jensen (ed.) Progress in Pain Research and Management, Vol. 2. Seattle: IASP Publications, 1994: 495–510.
- Boivie J. Central pain. In: PD Wall, R Melzack (eds.) Textbook of Pain. 3rd edn. Edinburgh: Churchill Livingstone, 1999: 871–902.
- Costigan M, Woolf CJ Pain: molecular mechanisms. J Pain 2000; 1(Suppl. 1): 35–44.
- Dickenson AH A cure for wind-up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990; 11: 307–309.
- Dickenson AH, Sullivan AF Evidence for a role of the NMDA receptor in the frequency dependent potentiation of rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987; 26: 1235–1238.
- Eide PK Clinical trial of NMDA-receptor antagonist as analgesics. In: M Devor, MC Rowbotham, Z Wiesenfeld-Hallin (eds.) Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management, Vol. 16. Seattle: IASP Press, 2000: 817–832.
- Eide PK, Jørum E, Stubhaug A. Relief of post-herpetic neuralgia with the N-methyl-d-aspartic receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 54: 347–354.
- Farrar JT What is clinically meaningful: outcome measures in pain clinical trials. Clin J Pain 2000; 16: S106–S112.
- Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996; 64: 283–291.
- Fields HL Pain Syndromes in Neurology. London: Butter-worth, 1990: 286.
- Galer BS, Jensen MP Development and preliminary validation of a pain measure specific to neuropathic pain. The Neuropathic Pain Scale. Neurology 1997; 48: 332–338.
- Gottrup H, Nielsen J, Arendt-Nielsen L, Jensen TS The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury. Pain 1998; 75: 321–329.
- Gottrup H, Andersen J, Arendt-Nielsen L, Jensen TS Psychophysical examination in patients with postmastectomy pain. Pain 2000; 87: 275–284.
- Gracely RH, Lynch SA, Bennett GJ Painful neuropathy: altered central processing, maintained dynamically by peripheral input. Pain 1992; 51: 175–194.
- Hansson P, Lindblom U. Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain. In: Willis WD Jr Hyperalgesia and Allodynia. New York: Raven Press, 1992: 335–343.
- Jensen TS Mechanisms of neuropathic pain. In: JN Campbell, (ed.) Pain 1996, An Updated Review. Seattle: IASP Press, 1996: 77–86.
- Jensen TS, Brennum J. The relation of thermally and mechanically evoked pain to pathological pain. In: J Boivie, P Hansson, U Lindblom (ed.) Touch, Temperature and Pain in Health and Disease: Mechanisms and Assessment Progress in Pain Research and Management, Vol. 3. Seattle: IASP Press, 1994: 373–388.
- Jensen TS, Gottrup H. Assessment of neuropathic pain. In: D Justins, A Rice, E Warfield (eds.) Clinical Pain Management. London: Arnold, 2002(in press).
- Jensen TS, Lenz FA Central post-stroke pain: a challenge for the scientist and the clinician. Pain 1995; 61: 161–164.
-
Jensen TS,
Nikolajsen L.
Pre-emptive analgesia in phantom pain: an update. In: J Sandkühler,
B Bromm,
GF Gebhart (eds.)
Nervous System Plasticity and Chronic Pain Progress in Brain Research, Vol. 129. Amsterdam: Elsevier, 2000: 493–503.
10.1016/S0079-6123(00)29036-5 Google Scholar
- Jensen TS, Gottrup H, Sindrup SH, Bach FW The clinical picture of neuropathic pain. Eur J Pharmacol 2001; 429: 1–11.
- Kilo S, Schmelz M, Koltzenburg M, Handwerker HO Different patterns of hyperalgesia induced by experimental inflammation in human skin. Brain 1994; 117: 385–396.
- Koltzenburg M. Painful neuropathies. Curr Opin Neurol 1998; 11: 515–521.
- Koltzenburg M, Lundberg LER, Torebjörk HE Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992; 51: 207–219.
- La Motte RH, Shain CN, Simone DA, Tsai E-FP Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991; 66: 190–211.
- Lindblom U. Analysis of abnormal touch, pain and temperature sensation in patients. In: J Boivie, P Hansson, U Lindblom (eds.) Touch, Temperature and Pain in Health and Disease: Mechanisms and Assessment Progress in Pain Research and Management, Vol. 3. Seattle: IASP Press, 1994: 63–84.
- McQuay HJ, Moore RA An Evidence-based Resource for Pain Relief. Oxford: Oxford University Press, 1998.
- Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277–299.
- Melzack R. The short-form McGill Pain Questionnaire. Pain 1987; 30: 191–197.
- Mendell LM, Wall PD Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206: 97–99.
- Merskey H, Bogduk N, (eds.) Classification of chronic pain, 2nd ed. Seattle: IASP Press, 1994: 209–214.
- Nikolajsen L, Jensen TS Phantom limb pain: an update. Br J Anaesth 2001(in press).
- Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996; 67: 69–77.
- Nikolajsen L, Ilkjær S, Jensen TS Effect of preoperative extradural bupivacaine and morphine on stump sensation in lower limb amputees. Br J Anaesth 1998; 81: 348–354.
- Petersen KL, Fields HL, Brennum J, Sandroni P, Rowbotham MC Capsaicin evoked pain and allodynia in postherpetic neuralgia. Pain 2000; 88: 125–133.
- Rowbotham MC, Fields HL The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 1996; 119: 347–354.
- Sindrup SH, Jensen TS Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 389–400.
- Sindrup SH, Jensen TS Pharmacological treatment of pain in neuropathies. Neurology 2000; 55: 915–920.
- Sindrup SH, Jensen TS, Andersen G, Madsen C, Brøsen K, Smith T, Jensen TS Tramadol relieves pain and allodynia in polyneuropathy. A randomised, double-blind, placebo-controlled trial. Pain 1999; 83: 85–90.
- Terrence CF, Jensen TS Trigeminal neuralgia and other facial neuralgias. In: J Olesen, P Tfelt-Hansen, KMA Welch (eds.) The Headaches, 2nd edn. New York: Raven Press; 1999: 929–938.
- Vestergaard K, Nielsen J, Andersen G, Ingemann-Nielsen M, Arendt-Nielsen L, Jensen TS Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain 1995; 61: 177–186.
- Ware JE, Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.
- Wasner G, Schattschneider J, Heckmann K, Maier C, Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001; 124: 587–599.
- Woolf CJ, Mannion RJ Neuropathic pain: aetiology, symptoms, mechanisms and management. Lancet 1999; 353: 1959–1964.
- Woolf CJ, Salter MW Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765–1768.
- Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, Lipton R, Loeser JD, Payne R, Torebjork E. Towards a mechanism-based classification of pain? Pain 1998; 77: 227–229.